FDA Clears BD Chlamydia, Gonorrhea Assays | GenomeWeb

NEW YORK (GenomeWeb) – BD Diagnostics said today the US Food and Drug Administration has cleared for marketing the BD ProbeTec Chlamydia trachomatis Qx Amplified DNA Assay and the BD ProbeTec Neisseria gonorrhea Qx Amplified DNA Assay on the BD Viper LT system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.